Direct comparison of umbilical cord-derived versus adipose-derived mesenchymal stem cell exosomes reveals distinct therapeutic profiles for skin aging. UC-MSC exosomes, enriched with transforming growth factor-beta and PDGF-BB, demonstrated superior immunomodulatory activity and more pronounced reduction of senescence-associated secretory phenotype markers in UV-damaged human skin. AD-MSC exosomes showed higher VEGF content, driving stronger angiogenesis and enhanced collagen and hyaluronic acid production. Both variants effectively increased fibroblast proliferation, reduced cellular senescence, and inhibited melanogenesis without harming melanocyte viability. This represents the first standardized head-to-head comparison using physiologically relevant human skin models, moving beyond the heterogeneous animal studies that have dominated this field. The complementary profiles suggest strategic clinical applications: UC-MSC exosomes for inflammatory skin conditions and photoaging, while AD-MSC variants excel in structural rejuvenation and hydration. However, this remains ex vivo research requiring clinical validation. The findings advance personalized regenerative dermatology by providing evidence-based guidance for selecting exosome sources based on specific skin aging mechanisms rather than availability alone.